Two years ago, Angelina Jolie made headlines for her decision to undergo a double mastectomy. Recently, she also elected to remove her fallopian tubes and ovaries in an effort to reduce her elevated risk of ovarian cancer. Jolie, along with many others, is a carrier of BRCA, a genetic mutation that dramatically increases the chance of developing breast, ovarian, prostate, and other cancers.
The heavy media coverage regarding Jolie’s story highlights the importance of Basser Research Center and its status as the premier facility in the world to focus solely on BRCA1 and 2 research. Founded in 2012 by Mindy and Jon Gray at the University of Pennsylvania’s Abramson Cancer Center, Basser’s extensive BRCA exploration spans prevention, early detection, treatment, survivorship, outreach, and risk assessment. At its core, the Basser Center hopes to eradicate BRCA cancers.
“In 2012, my husband Jon and I founded the Basser Research Center for BRCA at Penn’s Abramson Cancer Center. The Basser Center stands as the first comprehensive BRCA-focused institution in the world and is committed to funding cutting-edge scientific research and supporting BRCA-positive individuals and their families with counseling and treatment. Our goal is simple: to find, inspire and fund the best ideas- wherever they come from– to encourage collaboration by researchers around the world. We are singularly focused on ending this multi-generational cycle of pain and untimely death.” – Mindy Gray
Please visit their website and join us as we spread the word about genetic testing, available options, and ways to help others dealing with BRCA related cancers.
We are thrilled to be developing their new brand identity, and to be a part of their lasting success!